- Global Pharma News & Resources

Worldwide Protein Expression Industry to 2028 - by Product, Services, Application, End-user and Geography -

DUBLIN--(BUSINESS WIRE)--The "Global Protein Expression Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Competent Cells, Expression Vectors, Reagents and Instruments); Services; Application; End User and Geography" report has been added to's offering.

The global protein expression market is expected to reach US$ 4,000.67 million in 2028 from US$ 2,221.73 million in 2021. The market is estimated to grow with a CAGR of 8.8% from 2021-2028.

The growth of the market is attributed to some key driving factors such increasing incidence of chronic diseases, growth in the geriatric population, and increasing demand for protein biologics. Emerging economies are likely to create significant growth opportunities for players in the market.

Protein expression is a process in which proteins are synthesized, modified and regulated. Protein expression involves laboratory techniques & procedures which aid in manufacture of proteins. The technique allows to produce and purify the desired protein, either inside or outside a cell. The proteins synthesized using protein expression technique can be used for industrial processes or to diagnose and to treat diseases. Protein expression provides substrates or enzymes required for further analysis.

Technological advancements have increased the adoption of molecular biology techniques for developing therapeutic or treatment modalities. Many therapeutic modalities utilize genomic, transcriptomic information that facilitates the discovery of biomarkers to monitor diseases and predicts their risks. The use of personalized or precision medicines has dramatically risen due to the awareness of genetic variations among people. For instance, mRNA-mediated therapy is used to treat several diseases. The treatment is characterized by decreased immunogenicity, superior translation efficacy, enhanced stability, pharmaceutical safety, and transient protein expression since only the mRNA is modified without incorporating the host genome.

Similarly, the pharmaceutical and biotechnology industries have developed various techniques to treat cancer and neurodegenerative diseases. The transient gene expression technique has led to significant developments in the research related to neurotrauma and neurodegenerative, and introduced precision medicines for these conditions. Technological advancements in epigenetics, genetics, and proteomics support the development of therapeutics for the treatment of various genetic and rare genetic diseases caused by single and multiple cell disorders.

The Precision Medicine Initiative, which was launched in the US in 2015, has enhanced the use of genetic engineering, genomics, and proteomics, thereby increasing protein expression techniques. Thus, the continuous research and development activities and growing government initiatives to support precision medicine boost the adoption of protein expression techniques.

Reasons to buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Protein Expression market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global Protein Expression market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Market Dynamics


  • Increasing Applications of Protein Expression
  • Growing Adoption of Precision Medicines


  • High Cost of Products


  • Growing Funding for Genomics and Proteomics Research

Future Trends

  • Growing Traction Toward Recombinant Proteins

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • GenScript
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Takara Bio Inc.
  • Bio-Rad Laboratories, Inc.
  • New England Biolabs.
  • Promega Corporation
  • Oxford Expression Technologies Ltd

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 13-Oct-2021